FELICE, CARLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 912
EU - Europa 171
AS - Asia 72
OC - Oceania 1
Totale 1.156
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 911
IT - Italia 73
CN - Cina 62
FI - Finlandia 32
GB - Regno Unito 17
DE - Germania 15
FR - Francia 5
IE - Irlanda 5
SE - Svezia 4
SG - Singapore 3
UA - Ucraina 3
AT - Austria 2
DK - Danimarca 2
IN - India 2
NL - Olanda 2
AU - Australia 1
BE - Belgio 1
CA - Canada 1
CZ - Repubblica Ceca 1
EE - Estonia 1
ES - Italia 1
HK - Hong Kong 1
HR - Croazia 1
KR - Corea 1
LU - Lussemburgo 1
MD - Moldavia 1
MM - Myanmar 1
MY - Malesia 1
NO - Norvegia 1
PL - Polonia 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
Totale 1.156
Salva come PNG Salva come JPEG
Città #
Fairfield 146
Chandler 129
San Diego 65
Medford 60
Princeton 60
Roxbury 53
Ashburn 50
Padova 39
Cambridge 36
Houston 36
Woodbridge 32
Helsinki 28
Seattle 28
Beijing 26
Wilmington 20
Ann Arbor 16
Des Moines 5
Dublin 5
Treviso 5
Edinburgh 4
Lappeenranta 4
London 4
New York 4
Ogden 4
Rome 4
Bari 3
Menlo Park 3
Singapore 3
Acton 2
Chicago 2
Florence 2
Hounslow 2
Los Angeles 2
Napoli 2
Narragansett 2
Schio 2
Venice 2
Verona 2
Vienna 2
Amsterdam 1
Atlanta 1
Belgrade 1
Borås 1
Brussels 1
Chisinau 1
Dallas 1
Falkenstein 1
Frankfurt am Main 1
Fuzhou 1
Istanbul 1
Kharkiv 1
Kuala Lumpur 1
Kyiv 1
Las Vegas 1
Madrid 1
Melbourne 1
Mumbai 1
Nagold 1
Nay Pyi Taw 1
New Bedfont 1
Norwalk 1
Nürnberg 1
Oslo 1
Palo Alto 1
Prague 1
Prescot 1
Redmond 1
Rockville 1
Stockholm 1
Tallinn 1
Venezia 1
Vezzano sul Crostolo 1
Vittorio Veneto 1
Washington 1
Zagreb 1
Totale 930
Salva come PNG Salva come JPEG
Nome #
Impact of COVID-19 Outbreak on Healthcare Workers in Italy: Results from a National E-Survey 75
Use of RAAS inhibitors and risk of clinical deterioration in COVID-19: results from an Italian cohort of 133 hypertensives 74
GSK-3 Inhibition Modulates Metalloproteases in a Model of Lung Inflammation and Fibrosis 74
Coronavirus disease 2019 in Italy: the Veneto Model 69
The emerging role of nutraceuticals in cardiovascular calcification: Evidence from preclinical and clinical studies 49
Comparison between dexamethasone and methylprednisolone therapy in patients with COVID-19 pneumonia admitted to non-intensive medical units 47
Red flags for appropriate referral to the gastroenterologist and the rheumatologist of patients with inflammatory bowel disease and spondyloarthritis 45
Changes in hospital admissions and complications of acute appendicitis during the {COVID}-19 pandemic: A systematic review and meta-analysis 42
Fibrolamellar hepatocellular carcinoma with biliary tumor thrombus: An unreported association 31
Surgical Management of Hemorrhoidal Disease in Inflammatory Bowel Disease: A Systematic Review with Proportional Meta‐Analysis 27
Impact of Hypogammaglobulinemia on the Course of COVID-19 in a Non-Intensive Care Setting: A Single-Center Retrospective Cohort Study 24
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study 22
A case of hereditary hemorrhagic telangiectasia associated with crohn's disease successfully treated with infliximab 22
AID in aging and autoimmune diseases 22
Vascular involvement in inflammatory bowel disease: Pathogenesis and clinical aspects 21
Biological therapies for inflammatory bowel disease: Controversies and future options 21
Total Abdominal Colectomy for Refractory Ulcerative Colitis. Surgical Treatment in Evolution 21
Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents 19
Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: An open-label pilot study 19
Biomarkers of Neutrophil Activation in Patients with Symptomatic Chronic Peripheral Artery Disease Predict Worse Cardiovascular Outcome 18
Anal Fistula Human Amniotic Membrane Endosealing (F-HAME): A Proof of Concept Study 18
Achievement of sustained deep remission with Adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis 18
Comparison of Quantiferon-TB Gold versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease patients 17
Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: Effects of combined therapy with immunosuppressants 17
Intima-media thickness in inflammatory bowel disease patients: A still open question [9] 16
Use of infliximab in particular clinical settings: Management based on current evidence 16
Ileal Crohn's disease: CEUS determination of activity 16
FOXP3+ T regulatory cell modifications in inflammatory bowel disease patients treated with anti-TNF α agents 15
New biological agents for the treatment of the "high risk" IBD patients 14
Infliximab: A review of its use in the treatment of inflammatory Bowel disease 14
Non-biological therapy in inflammatory bowel disease-old and new evidence 14
Clinical management of rheumatologic conditions co-occurring with inflammatory bowel diseases 14
Inducing remission of ulcerative colitis: Are clinicians better equipped than ever? 13
Anti TNF-α therapy for ulcerative colitis: current status and prospects for the future 13
Infliximab in steroid-dependent ulcerative colitis: Effectiveness and predictors of clinical and endoscopic remission 13
New therapeutic approach in inflammatory bowel disease 13
Discontinuation of Infliximab in Patients With Ulcerative Colitis Is Associated With Increased Risk of Relapse: A Multinational Retrospective Cohort Study 12
Therapeutic drug monitoring is more cost-effective than a clinically based approach in the management of loss of response to infliximab in inflammatory bowel disease: An observational multicentre study 12
Acute cytomegalovirus infection as a possible trigger for pulmonary thromboembolism in a patient with steroid-refractory ulcerative colitis 12
Benefit–risk assessment of golimumab in the treatment of refractory ulcerative colitis 11
Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year 11
Reply to Dr. Kotze's and Dr. Yamamoto's letter 11
Etrolizumab in moderate-to-severe ulcerative colitis 11
Natalizumab in Crohn's disease: Past and future areas of applicability 10
Cytokines in Spondyloarthritis and Inflammatory Bowel Diseases: From Pathogenesis to Therapeutic Implications 9
NETosis in Acute Thrombotic Disorders 9
IBD: Infliximab dose optimization in IBD - Proactive or reactive? 9
The role of healthcare providers in accompanying biosimilars in inflammatory bowel diseases 9
What is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients? 9
Management of perianal fistulas in Cohn's disease: An up-to-date review 8
Therapeutic drug monitoring of anti-TNF-α agents in inflammatory bowel diseases 7
The miR-200 family is increased in dysplastic lesions in ulcerative colitis patients 7
Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis 7
Role of HMGB1 as a suitable biomarker of subclinical intestinal inflammation and mucosal healing in patients with inflammatory bowel disease 7
Multidisciplinary management of patients with coexisting inflammatory bowel disease and spondyloarthritis: A Delphi consensus among Italian experts 7
TREM1 predicts response to anti-tumor necrosis factor in inflammatory bowel diseases: Towards precision medicine 7
Anoplasty for anatomical anal stenosis: systematic review of complications and recurrences 7
Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study 6
Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study 6
Venous thromboembolism in patients with inflammatory bowel disease: Focus on prevention and treatment 6
Risk factors and timing for colectomy in chronically active refractory ulcerative colitis: A systematic review 6
Review article: Selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases 6
Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease 6
Intestinal Inflammation is Linked to Hypoacetylation of Histone 3 Lysine 27 and can be Reversed by Valproic Acid Treatment in Inflammatory Bowel Disease Patients 6
Therapeutic Role of Appendectomy in Ulcerative Colitis: A Tangible Perspective? 6
Chest radiography findings of COVID-19 pneumonia: a specific pattern for a confident differential diagnosis 5
The Importance of Endoscopy with Biopsy: Real-World Evidence of Gastrointestinal Involvement in Primary Immunodeficiency in Two Main Northern Italian Centres 3
Decline of gastric cancer mortality in common variable immunodeficiency in the years 2018-2022 2
EPIGENETIC AND METABOLIC REPROGRAMMING OF FIBROBLASTS IN CROHN'S DISEASE STRICTURES REVEALS HISTONE DEACETYLASES AS THERAPEUTIC TARGETS 1
SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves 1
Totale 1.235
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.933
article - articoli 11.933
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.866
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202032 0 0 2 1 2 1 3 3 2 6 5 7
2020/202179 3 4 4 1 10 10 7 5 8 9 1 17
2021/2022565 22 17 45 2 3 4 24 42 10 3 261 132
2022/2023328 99 6 4 21 48 41 2 42 24 7 30 4
2023/2024231 16 19 45 30 20 39 34 8 16 3 1 0
Totale 1.235